Bipolar I
Resources for Patients and Caregivers
Bipolar I Disorder— defined by manic episodes that last at least 7 days, or by manic symptoms that are so severe that the person needs immediate hospital care. Usually, depressive episodes occur as well, typically lasting at least 2 weeks.
Cluster Number:
Wiki Number: 08-Bipolar I
Diagnosis: This requires just one full manic episode where the individual may be “high” for several days.
US Patients: 1% of the US population in their lifetimes.
World Patients:
Sex Ratio:
Age Onset:
Brain Area:
Symptoms: Typically it will be followed by one or more depressive stretches of time.
Progression: Relatively good, may last 6 months or 25% go to PTSD or Major Depressive Disorder
Causes:
Medications:Can be reduced by other prescribed drugs.
Therapies:
Youtube Video: Faces of Bipolar Disorder (PART 2) “Bipolar Type 1”
Amazon or Library Book: Bipolar Disorder 1
How to Survive and Thrive
Click the book to link or order from Amazon.
Support Group: dsballiance.org; 800-326-3632
(Depression and Bipolar Support Alliance)
Contact your local Social Security offic for possible Disability Benefits through their Disability Determination Services,
Section 12.04.
Resources for Physicians, Counselors and Researchers
4 CURRENT ARTICLES
FROM PUBMED
The world-wide medical research
reports chosen for each diagnosis
Clicking each title opens the
PubMed article’s summary-abstract.
- Cannabis and Cannabinoids in Mood and Anxiety Disorders: Impact on Illness Onset and Course, and Assessment of Therapeutic Potentialby Sabrina L Botsford on April 16, 2025
CONCLUSIONS AND SCIENTIFIC SIGNIFICANCE: These conclusions are limited by a lack of well-controlled longitudinal studies. We suggest that future research be directed toward high-quality, prospective studies of cannabis in clinical populations with mood and ADs, in addition to controlled studies of cannabinoid constituents and pharmaceuticals in these populations.Reprinted from Am J Addict 2020; 29:9-26, with permission from American Academy of Addiction Psychiatry. Copyright © 2019.
- Targeted Research and Treatment Implications in Women With Depressionby Marie E Gaine on April 16, 2025
Women with a history of traumatic experience, particularly adversity encountered during childhood, have an increased risk of developing depression. The authors review the biological mechanisms associating trauma with depression, including the role of the hypothalamic-pituitary-adrenal axis. Additionally, the psychosocial and cultural considerations associating traumatic experience with depression are discussed, and current gaps in knowledge about biological mechanisms, psychosocial factors, and...
- Co-Occurring Bipolar and Substance Use Disorders: A Review of Impacts, Biopsychosocial Mechanisms, Assessment, and Treatmentby Sarah H Sperry on April 16, 2025
Individuals with bipolar disorder are at significant risk for having a co-occurring substance use disorder-particularly, alcohol and cannabis use disorders. Having a co-occurring substance use disorder is associated with a more pernicious clinical course, lower quality of life, and poorer treatment outcomes. Despite its increased morbidity, there is little research and clinical evidence-based guidelines on the treatment of individuals with co-occurring bipolar and substance use disorders. This...
- Patient Self-Diagnosis: Physician Engagement Tools to Compete With TikTokby Dorothy E Stubbe on April 16, 2025
No abstract